Papers
1
Total Citations
11
H-Index
1
About
Dr. Alessia Zorz is a leading researcher at the intersection of neonatology and healthcare technology, with a primary focus on medication safety in the Neonatal Intensive Care Unit (NICU). Her most cited work, "Robotic Therapy: Cost, Accuracy, and Times. New Challenges in the Neonatal Intensive Care Unit" (2019, 11 citations), addresses the critical vulnerabilities of preterm newborns to medication errors. Dr. Zorz’s major contribution lies in evaluating the potential of robotic medication compounding to revolutionize NICU pharmacy workflows. By systematically analyzing the trade-offs between cost, accuracy, and preparation times, her research provides a foundational framework for integrating automation into high-stakes neonatal care. This work highlights how robotic systems can mitigate human error while navigating the unique pharmacokinetic challenges of extremely low-birth-weight infants. Though her citation count is emerging, Dr. Zorz’s research is pivotal for clinicians and hospital administrators seeking evidence-based solutions to enhance patient safety. Her findings underscore a paradigm shift toward precision and efficiency in neonatal pharmacotherapy, positioning her as a key voice in the ongoing dialogue about technology’s role in protecting the most vulnerable patients.
Research Focus
Key Achievements
Top Papers
- 1